ResearchMatch.org is a web-based registry that is connecting participants and researchers for clinical studies.
A new analytical tool points to genes that act together to increase disease risk.
Treatment with a drug used to prevent organ rejection partially reverses the course of tuberous sclerosis, research in mice suggests.
Drugs that target “epigenetic” changes may help treat or slow the progression of lung cancer.
Investigators at Vanderbilt-Ingram Cancer Center and several other centers may be one step closer to finding out why some melanoma patients relapse after treatment with a promising new drug.
A protein involved in repairing DNA damage associated with gastric reflux may play a tumor suppressor role in the esophagus and could represent a target for therapies to combat esophageal cancer.
Accessibility Tools